血液型検査試薬の市場規模、シェア、分析：製品別（消耗品、機器）、検査タイプ別（血液型と表現型、抗体スクリーニング、クロスマッチング検査、抗体同定、クームズ検査、抗原タイピング）、技術別（PCR）- ベースおよびマイクロアレイ技術、アッセイベースの技術、超並列シーケンス技術、血清学、その他）、エンドユーザー別（病院、血液銀行、臨床検査室）および地域予測、2022 〜 2032
血液型分析試薬は、ABO、ケル、MNS、アカゲザル血液型抗原などの血液型のヒト抗原を確認するために使用されます。RhD および ABO 血液型システムは、輸血における重要な必須血液型です。血液型は、血液型の ABO 抗原や人間の赤血球の表面にある他のいくつかの抗原などのタンパク質または分子 (炭水化物) によって識別されます。
血液型検査試薬市場は、血液型検査と輸血の需要の高まりと交通事故などの緊急事態の増加により、予測期間中に8.4%のCAGRで成長し、29億ドルに達すると予想されます。さらに、予測期間中はヘルスケアおよび関連施設の普及拡大により、血液型検査試薬市場の成長が促進されるでしょう。
目次
Table of Content
1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Blood Grouping Reagents Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Blood Grouping Reagents Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Blood Grouping Reagents Market - Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Market Analysis
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2.Economic
8.2.3.Social
8.2.4.Technological
9. Blood Grouping Reagents Market
9.1. Overview
9.2. Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. Blood Grouping Reagents Market Size & Forecast 2022A-2032F
10.1.Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Product
10.3.1.1.Consumables
10.3.1.1.1.By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Instruments
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2.Market Share (%) 2022-2032F
10.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.By Test Type
10.3.2.1. Blood Group and Phenotype
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2.Market Share (%) 2022-2032F
10.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.2.Antibody Screening
10.3.2.2.1.By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3.Cross-Matching Tests
10.3.2.3.1.By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.4.Antibody Identification
10.3.2.4.1. By Value (USD Million) 2022-2032F
10.3.2.4.2.Market Share (%) 2022-2032F
10.3.2.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.5.Coombs Tests
10.3.2.5.1.By Value (USD Million) 2022-2032F
10.3.2.5.2.Market Share (%) 2022-2032F
10.3.2.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.6.Antigen Typing
10.3.2.6.1.By Value (USD Million) 2022-2032F
10.3.2.6.2. Market Share (%) 2022-2032F
10.3.2.6.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.By Technique
10.3.3.1. PCR-Based and Microarray Technique
10.3.3.1.1. By Value (USD Million) 2022-2032F
10.3.3.1.2.Market Share (%) 2022-2032F
10.3.3.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.2.Assay-Based Techniques
10.3.3.2.1.By Value (USD Million) 2022-2032F
10.3.3.2.2. Market Share (%) 2022-2032F
10.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.3.Massively Parallel Sequencing Techniques
10.3.3.3.1.By Value (USD Million) 2022-2032F
10.3.3.3.2.Market Share (%) 2022-2032F
10.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.4.Serology
10.3.3.4.1. By Value (USD Million) 2022-2032F
10.3.3.4.2.Market Share (%) 2022-2032F
10.3.3.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.5.Others
10.3.3.5.1. By Value (USD Million) 2022-2032F
10.3.3.5.2.Market Share (%) 2022-2032F
10.3.3.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.4.By End User
10.3.4.1. Serology
10.3.4.1.1.By Value (USD Million) 2022-2032F
10.3.4.1.2. Market Share (%) 2022-2032F
10.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.4.2.Blood Banks
10.3.4.2.1. By Value (USD Million) 2022-2032F
10.3.4.2.2.Market Share (%) 2022-2032F
10.3.4.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.4.3.Clinical Laboratories
10.3.4.3.1. By Value (USD Million) 2022-2032F
10.3.4.3.2.Market Share (%) 2022-2032F
10.3.4.3.3.Y-o-Y Growth (%) 2022-2032F
11. North America Blood Grouping Reagents Market Size & Forecast 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test Type
11.3.2. By Product
11.3.3. By Technique
11.3.4. By End User
11.4.Country
11.4.1. United States
11.4.2.Canada
12. Europe Blood Grouping Reagents Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test Type
12.3.2.By Product
12.3.3.By Technique
12.3.4.By End User
12.4. Country
12.4.1.Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. Asia Blood Grouping Reagents Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test Type
13.3.2.By Product
13.3.3.By Technique
13.3.4.By End User
13.4. Country
13.4.1.India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. Middle East and Africa Blood Grouping Reagents Market Size & Forecast 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test Type
14.3.2.By Product
14.3.3.By Technique
14.3.4. By End User
14.4. Country
14.4.1.Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. Latin America Blood Grouping Reagents Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test Type
15.3.2.By Product
15.3.3.By Technique
15.3.4.By End User
15.4. Country
15.4.1.Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. Competitive Landscape
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. Company Profiles
17.1.Merck KGaA
17.1.1.Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4.Company Assessment
17.1.4.1.Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. Cardinal Health
17.3. Beckman Coulter Inc
17.4. Bio-Rad Laboratories Inc
17.5. Quotient Ltd.
17.6. Tulip Diagnostics
17.7. Diagast SAS
17.8. Atlas Medical
17.9. Fortress Diagnostics
17.10. Alpha Laboratories
17.11.BAG Diagnostics GmbH
17.12. Haemokinesis Pty Ltd
17.13. Aikang
17.14. Rapid Labs Ltd
17.15. Anamol Laboratories Pvt. Ltd.
17.16. Other Prominent Players
18. Appendix
19. Consultant Recommendation
